Copertina

Experimental Parkinsonism induced by tetanus toxin injected into basal ganglia

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Patrik Meglić, Petra Šoštarić, Davor Virag, Ana Knezović, Nikola Habek, Ornella Rossetto, Ivica Matak
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	British Journal of Pharmacology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Pharmacokinetics and pharmacodynamics of intranasal insulin in a rat brain
di: Jelena Osmanovic Barilar, et al.
Pubblicazione: (2025)

Population pharmacokinetics of rotigotine extended‐release microspheres for intramuscular injection in patients with early‐stage Parkinson's disease
di: Hong Sun, et al.
Pubblicazione: (2024)

Daidzein ameliorates nonmotor symptoms of manganese‐induced Parkinsonism in zebrafish model: Behavioural and biochemical approach
di: Balasubramanian Haridevamuthu, et al.
Pubblicazione: (2024)

Advanced prescription of injectable anticancer drugs: Safety assessment in a European Comprehensive Cancer Centre using the risk matrix approach
di: Alexandre Acramel, et al.
Pubblicazione: (2024)

A study on adverse events of botulinum toxin type A in real‐world applications: A FAERS database analysis
di: Weizhen He, et al.
Pubblicazione: (2025)

Monovalent glycoconjugates of sulforaphane prevent inflammation induced by lipopolysaccharide in human dendritic cells by inhibiting NF‐ĸB signalling pathway
di: Camila Leiva‐Castro, et al.
Pubblicazione: (2025)

Monovalent mannose‐glycoconjugates of sulforaphane reprogram human dendritic cells via NFATc1 to induce immune tolerance under inflammatory conditions
di: María Elena Angarita‐Planchez, et al.
Pubblicazione: (2025)

Model based comparison of cabotegravir pharmacokinetics following thigh and gluteal injections
Pubblicazione: (2024)

A phase I study to evaluate the safety, tolerance and pharmacokinetics of anti‐Shiga toxin hyperimmune equine F (ab′)2 fragments in healthy volunteers
di: Yanina Hiriart, et al.
Pubblicazione: (2024)

Vitamin D deficiency induces erectile dysfunction: Role of superoxide and Slpi
di: Miguel A. Olivencia, et al.
Pubblicazione: (2025)

Physiologically‐based pharmacokinetic modelling of long‐acting injectable cabotegravir and rilpivirine in pregnancy
di: Shakir Atoyebi, et al.
Pubblicazione: (2024)

Dexrazoxane protects against doxorubicin‐induced cardiotoxicity in susceptible human living myocardial slices: A proof‐of‐concept study
di: Jort S. A. van der Geest, et al.
Pubblicazione: (2025)

Matsupexole: A novel nonergot dopamine receptor agonist with sustained efficacy in a rat model of Parkinson's disease and limited off‐target activity
di: Takayuki Suzuki, et al.
Pubblicazione: (2026)

A novel marine‐derived mitophagy inducer ameliorates mitochondrial dysfunction and thermal hypersensitivity in paclitaxel‐induced peripheral neuropathy
di: Sangwoo Im, et al.
Pubblicazione: (2024)

Paediatric sepsis survivors are resistant to sepsis‐induced long‐term immune dysfunction
di: David F. Colón, et al.
Pubblicazione: (2024)

Preclinical pharmacokinetics of novel long‐acting tenofovir alafenamide/bictegravir solid injectable in rats
Pubblicazione: (2024)

A comprehensive review of cancer‐induced cardiac wasting
di: Alessia Lena, et al.
Pubblicazione: (2026)

Development of a population pharmacokinetic model for the novel long‐acting injectable antipsychotic risperidone ISM®
di: Christian Laveille, et al.
Pubblicazione: (2024)

Histone deacetylase inhibition mitigates cognitive deficits and astrocyte dysfunction induced by amyloid‐β (Aβ) oligomers
di: Luan Pereira Diniz, et al.
Pubblicazione: (2024)

Correction to “RTP801 is a critical factor in the neurodegeneration process of A53T a‐synuclein in a mouse model of Parkinson's disease under chronic restraint stress”
Pubblicazione: (2024)

Toll‐like receptor 4 mediates lipopolysaccharide‐induced emesis
di: Luping Liu, et al.
Pubblicazione: (2026)

The role of fluvoxamine in the treatment of endotoxin‐induced acute heart injury
di: Ilter Ilhan, et al.
Pubblicazione: (2026)

Targeting FDX1 by trilobatin to inhibit cuproptosis in doxorubicin‐induced cardiotoxicity
di: Jiajia Wei, et al.
Pubblicazione: (2025)

Revisiting the GRK2–NOX4 axis in cisplatin‐induced nephrotoxicity
di: Cheng Xue
Pubblicazione: (2026)

Schwann cell TRPA1 elicits reserpine‐induced fibromyalgia pain in mice
di: Evelyne Silva Brum, et al.
Pubblicazione: (2024)

Higher sensitivity to ouabain‐induced toxicity in human induced pluripotent stem cell‐derived cardiomyocytes than human adult heart tissue despite similar Na + /K + ‐ATPase pump current amplitudes
di: Djemail Ismaili, et al.
Pubblicazione: (2026)

Targeting the noradrenergic‐metabolic axis: A new strategy for sugar‐induced depression subtypes
di: Takatoshi Sakata, et al.
Pubblicazione: (2025)

Targeting the tyrosine kinase Src in endothelium attenuates inflammation and atherogenesis induced by disturbed flow
di: Huanyu Ding, et al.
Pubblicazione: (2024)

Empty lipid nanoparticles (eLNPs) with adjuvant activity induce potent immune responses
di: De‐Kui Qiu, et al.
Pubblicazione: (2026)

Cytochrome P450 1A1 influences obesity‐induced pulmonary hypertension
di: Joshua P. Dignam, et al.
Pubblicazione: (2025)

The thoracic perivascular adipose tissue spontaneously induces vasoconstriction through activation of α1‐adrenoceptors
di: Leonardo Gomes‐Pereira, et al.
Pubblicazione: (2025)

The protein disulfide isomerase A3 and osteopontin axis promotes influenza‐induced lung remodelling
di: Amit Kumar, et al.
Pubblicazione: (2024)

Implications and hidden toxicity of cardiometabolic syndrome and early‐stage heart failure in carfilzomib‐induced cardiotoxicity
di: Panagiotis Efentakis, et al.
Pubblicazione: (2024)

Matrix metalloproteinase inhibition protects against junctophilin‐2 proteolysis during doxorubicin‐induced cardiotoxicity
di: Wesam Bassiouni, et al.
Pubblicazione: (2025)

RETRACTION: Cloricromene, a Coumarine Derivative, Protects Against Collagen‐induced Arthritis in Lewis Rats
Pubblicazione: (2024)

Fn14 signalling participates in pristane‐induced murine lupus through exacerbating oxidative stress
di: Zhu Yan, et al.
Pubblicazione: (2026)

Aromatase inhibitors induce pain‐like musculoskeletal symptoms in mice: behavioural, pharmacological and pathophysiological characterization
di: Martial Caillaud, et al.
Pubblicazione: (2026)

6‴‐Feruloylspinosin ameliorates pressure overload‐induced heart failure with comorbid insomnia through the activation of RORα
di: Yan Yan, et al.
Pubblicazione: (2025)

Correction to “AQX‐1125, small molecule SHIP1 activator inhibits bleomycin‐induced pulmonary fibrosis”
Pubblicazione: (2024)

Assessment of the molecular mechanisms of drug‐induced hidden cardiotoxicity by a multi‐omics approach: The example of rofecoxib
di: Bennet Y. Weber, et al.
Pubblicazione: (2025)